Samlyn Capital, LLC Natera, Inc. Transaction History

Samlyn Capital, LLC

$5.65 Billion
Q1 2024

A detailed history of Samlyn Capital, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Samlyn Capital, LLC holds 1,984,579 shares of NTRA stock, worth $211 Million. This represents 3.21% of its overall portfolio holdings.

Number of Shares

1,984,579

Previous 362,100 448.07%

Holding current value

$211 Million

Previous $22.7 Million 700.27%

% of portfolio

3.21%

Previous 0.48%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$59.21 - $92.9 $112 Million - $176 Million	-1,890,222 Reduced 48.78%	1,984,579 $182 Million
Q4 2023 Feb 14, 2024	SELL	$37.55 - $62.64 $19.7 Million - $32.9 Million	-525,425 Reduced 11.94%	3,874,801 $243 Million
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $38.9 Million - $56 Million	895,686 Added 25.56%	4,400,226 $195 Million
Q2 2023 Aug 14, 2023	BUY	$47.08 - $55.16 $41.3 Million - $48.4 Million	877,319 Added 33.39%	3,504,540 $171 Million
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $64.5 Million - $103 Million	-1,763,151 Reduced 40.16%	2,627,221 $146 Million

Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $72.2 Million - $101 Million	2,113,236 Added 92.8%	4,390,372 $176 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $24.2 Million - $37.1 Million	655,121 Added 40.39%	2,277,136 $99.8 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $32 Million - $50.6 Million	1,136,524 Added 234.1%	1,622,015 $57.5 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $14.7 Million - $44.3 Million	485,491 New	485,491 $19.8 Million

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Account

Samlyn Capital, LLC Natera, Inc. Transaction History